Stress and the At-Risk Employee: a Long-Term Study of Eprosartan in Comparison to Standard Therapy

Trial Profile

Stress and the At-Risk Employee: a Long-Term Study of Eprosartan in Comparison to Standard Therapy

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 17 Nov 2006

At a glance

  • Drugs Eprosartan (Primary) ; ACE inhibitors; Beta-adrenergic receptor antagonists
  • Indications Hypertension
  • Focus Therapeutic Use
  • Acronyms STARLET
  • Most Recent Events

    • 01 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top